ArticleLupus2025
Associations of retention in care by visits or lupus-specific labs with acute care among young adults: A medicare cohort study.
Article in Lupus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
ObjectiveWhile quality lupus care is associated with lower lupus-related damage, the impact of access and process quality measures on other lupus outcomes remains unclear. Given high acute care in young adults, our objective was to evaluate two process quality measures, visit-based retention in lupus care and receipt of lupus-specific serologic testing, and associations with subsequent acute care use.MethodsThis cohort study used a 20% national sample of young adult (ages 18-35) Medicare beneficiaries with lupus to first measure visit-based retention in rheumatology care and receipt of ≥1 complement or dsDNA test over 1 year. Acute care use (Emergency Department visits and hospitalizations) was then assessed in the subsequent 6 months. Associations of visit-based retention and serologic testing with acute care were evaluated with Cox regressions.ResultsAmong 1036 young adults with lupus, acute care use was very high - nearly 60% at 6 months. Observed acute care-free survival time was longer in patients who had visit-based retention (154 vs 104 days,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.